Back to search

University of Edinburgh

Functional interpretation of human genetic risk variants for severe COVID-19

Abstract

dc:description.abstract

Genetic variation contributes to the development of complex human diseases. Genome-wide association studies (GWAS) have linked hundreds of thousands of genetic risk variants to disease; however, most of these do not themselves alter risk but rather are co-inherited with causal variants. Causal variants, their target genes, and the underlying mechanisms remain largely unknown and challenging to uncover. Approximately 90% of risk variants are located in the non-coding genome and may have tissue-specific, context-dependent, and combinatorial effects. Individual variants likely confer individually small functional effects. Consequently, experimental follow-up of disease-associated variants is required to identify causal variants and mechanisms. This thesis examines the functional impact of genetic risk variants associated with severe COVID-19, with a focus on effects in the lung. I employed a two-fold approach, prioritising candidate causal variants for functional studies and dissecting the underlying mechanism at one risk locus. To identify functional non-coding variants, I applied Self-Transcribing Active Regulatory Region sequencing (STARR-seq) in a lung epithelial cell line, testing >4,000 variants prioritised from two COVID-19 GWAS. Of those, 194 variants showed enhancer activity while 28 variants displayed allele-specific activity. Additionally, I tested all possible variant combinations which lie in close proximity. 16 combinations showed enhancer activity of at least one allele, revealing independent, additive and synergistic variant effects. By integrating my results with existing epigenetic, chromatin and RNA-sequencing datasets from the same cell line, as well as variant effect predictions, I prioritised a list of putative causal variants. In parallel, I investigated variants at the DPP9 locus which have been associated with both severe COVID-19 and lung fibrosis. DPP9 inhibits activation of NLRP1, the primary inflammasome sensor in barrier epithelial cells which is activated in response to SARS-CoV- 2 in airway epithelia. I identified a candidate causal variant residing in a putative DPP9 regulatory element. CRISPR/Cas9 deletion of this element resulted in moderately decreased DPP9 expression in a lung epithelial cell line. The variant-harbouring element overlaps a previously annotated two-exon transcript isoform lacking a defined coding sequence. Using RT-qPCR and target-enriched long-read RNA-sequencing in barrier epithelial cell lines, I found that this annotation is incorrect; rather, the variant resides in an alternative first coding exon (AFE) that is specific to barrier epithelial cells. AlphaFold3 predicts the AFE forms an alpha helix which moderately increases DPP9’s NLRP1 binding interface. The risk variant introduces a leucine to proline missense mutation (L8P), predicted to be helix-breaking. Enzymatic activity and co-immunoprecipitation assays showed the AFE isoform is functional and retains NLRP1 binding. These findings underscore the importance of considering alternative transcript isoforms when assessing functional consequences of genetic variants. Finally, to explore broader relevance, I identify 97 COVID-19 risk variants located in alternative coding exons annotated by Ensembl and a further 176 variants in unannotated alternative exons from long-read RNA-sequencing. The work presented in this thesis provides a framework for linking GWAS risk variants to function to better understand human disease. By integrating high throughput enhancer assays, long-read transcriptomics and genome editing, this thesis contributes novel insights into how coding and non-coding genetic variation may impact disease risk in relevant cell types. Identifying causal variants and their mechanisms provides a foundation for improved therapeutic targeting and personalised medicine based on genetic risk.

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Weykopf, Giovanna
Advisors dc:contributor.advisor
  • Bickmore, Wendy
  • Baillie, Kenneth
  • Biddie, Simon

Subjects

dc:subject × 5

Rights

Language dc:language.iso
en

Identifiers

dc:identifier.*

Chain of custody

source
Harvested from
University of Edinburgh
Base URL
era.ed.ac.uk/server/oai/request
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
citation

Weykopf, Giovanna. Functional interpretation of human genetic risk variants for severe COVID-19. 2025. https://era.ed.ac.uk/handle/1842/44391